Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|February 4, 2018
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancerJulia Foldi, Sarah Mougalian, Andrea Silber, et al.
Cancer Research|March 5, 2022
Comprehensive Analysis of Metabolic Isozyme Targets in CancerMichal Marczyk, Vignesh Gunasekharan, David Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Quantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancerMorgan Elizabeth Cody, Hung-Ching Rick Chang, Julia Foldi, et al.
NPJ Breast Cancer|February 9, 2021
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast CancerKim R M Blenman, Michal Marczyk, Thomas Karn, et al.
NPJ Breast Cancer|June 8, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giulia Viale, Mario Giuliano, et al.
Future Oncology (London, England)|June 22, 2026
Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-BreastJulia Foldi, Gregory Hogan, Katherine Johansen Taber, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative StudiesNeil Carleton, Alexander C Chang, Fangyuan Chen, et al.
Pageof 5